Quick answer: latest quarter results, by ticker or company name

Reported Q: Q1 2025 Rev YoY: +20.9% EPS YoY: +35.3% Move: +1.57%

Boston Scientific

0HOY.L

$77.29 1.57%

Exchange LSE Sector Healthcare Industry Medical Equipment Services

Q1 2025

Published: May 1, 2025

Company Status Snapshot

Fast view of the latest quarter outcome for 0HOY.L

Reported

Report Date

May 1, 2025

Quarter Q1 2025

Revenue

4.66B

YoY: +20.9%

EPS

0.45

YoY: +35.3%

Market Move

+1.57%

Previous quarter: Q4 2024

Follow this company to get upcoming quarter alerts automatically.

Earnings Highlights

Revenue of $4.66B up 20.9% year-over-year
EPS of $0.45 increased by 35.3% from previous year
Gross margin of 68.8%
Net income of 674.00M
""I think there's a significant opportunity for us in the neurostimulation market as we continue to innovate and expand our product offerings. These advancements are not just filling gaps but creating new markets."" - Michael Mahoney (CEO)

0HOY.L

Boston Scientific Corporation

Period Q1 2025

Currency USD

Report Type Quarterly Earnings

Generated Feb 9, 2026

Executive Summary

In Q1 2025, Boston Scientific Corporation reported robust growth with revenues reaching $4.66 billion, reflecting a 20.93% increase year-over-year and a sequential improvement of 2.24%. The company's operating income surged by 36.44% compared to the previous year, illustrating effective cost management and strategic pricing amid a recovering healthcare sector. Net income was reported at $674 million, a significant increase of 36.44% year-over-year, emphasizing the company's operational efficiency and strong demand for its medical devices. This quarter's performance indicates resilience and adaptability in a competitive market environment, fitting well with Boston Scientific's strategic growth objectives.

Key Performance Indicators

Revenue

Increasing

4.66B

QoQ: 2.24% | YoY: 20.93%

Gross Profit

Increasing

3.21B

68.84% margin

QoQ: 3.72% | YoY: 21.27%

Operating Income

Increasing

921.00M

QoQ: 36.44% | YoY: 36.44%

Net Income

Increasing

674.00M

QoQ: 19.08% | YoY: 36.44%

EPS

Increasing

0.46

QoQ: 21.05% | YoY: 35.29%

Revenue Trend

Margin Analysis

Financial Highlights

Revenue Performance:
- Total revenue reached $4.66 billion, showcasing strong demand across the company's segments.
- Year-over-Year (YoY) growth of 20.93% highlights the company's recovering market share post-pandemic.

Profitability Metrics:
- Gross profit for the quarter was $3.21 billion (67.8% gross profit margin), up from $2.65 billion YoY.
- Operating income was $921 million, indicating a solid operating margin of 19.75%, benefiting from stringent cost control measures.
- Net income reached $674 million, boosting the net income margin to 14.54%.

Earnings Per Share (EPS):
- Reported EPS of $0.46, a 35.29% YoY increase, positions the company favorably for investor sentiment.

These metrics illustrate Boston Scientific's capacity for sustained growth and profitability driven by ongoing innovation and demand for its diverse product line.

Income Statement

Metric	Value	YoY Change	QoQ Change
Revenue	4.66B	20.93%	2.24%
Gross Profit	3.21B	21.27%	3.72%
Operating Income	921.00M	36.44%	36.44%
Net Income	674.00M	36.44%	19.08%
EPS	0.46	35.29%	21.05%

Key Financial Ratios

Gross Profit Margin

Excellent

68.80%

Gross profit margin is exceptional, indicating strong pricing power and operational efficiency

Operating Profit Margin

Good

20.10%

Operating margin is healthy and competitive within industry standards

Net Profit Margin

Good

14.50%

Net profit margin is healthy and competitive within industry standards

P/E Ratio

High Growth

54.88x

Very high P/E indicates aggressive growth expectations, higher risk

Historical Earnings Comparison

Period	Revenue ($M)	EPS ($)	YoY Growth	Report
Q2 2025	5,061.00	0.53	+22.8%	View
Q1 2025	4,663.00	0.45	+20.9%	View
Q4 2024	4,561.00	0.38	+22.4%	View
Q3 2024	4,209.00	0.32	+19.3%	View
Q2 2024	4,120.00	0.22	+14.5%	View

0HOY.L

Boston Scientific

Q2 2025 Report

Boston Scientific Corporation (0HOY.L) QQ2 2025 Financial Results: Strong Growth Driven by Strategic Innovations...

Read full report

0HOY.L

Boston Scientific

Q4 2024 Report

Boston Scientific Corporation (0HOY.L) Q4 2024 Financial Analysis: Strong Revenue Growth Amidst Market Expansion...

Read full report

0HOY.L

Boston Scientific

Q3 2024 Report

Boston Scientific Corporation (0HOY.L) Q3 2024 Financial Analysis: Steady Growth Amid Challenges...

Read full report

0HOY.L

Boston Scientific

Q2 2024 Report

Boston Scientific Corporation (0HOY.L) Q2 2024 Financial Results Report: Evaluating Robust Growth Amid Market Challenges...

Read full report

Boston Scientific (0HOY.L) Q1 2025 Earnings Report

Company Status Snapshot

Earnings Highlights

Executive Summary

Key Performance Indicators

Revenue Trend

Margin Analysis

Financial Highlights

Income Statement

Key Financial Ratios

Management Insights Available for Members

Peer Comparison Available for Members

Investment Outlook & SWOT Available for Members

Historical Earnings Comparison

More 0HOY.L Quarterly Reports

0HOY.L

0HOY.L

0HOY.L

0HOY.L

Q1 2025 Reports in Healthcare Sector

0HJI.L

0HAV.L

Related Financial Data

Sector Analysis: Healthcare

0HOY.L Full Profile

0HOY.L Financial Statements

Earnings Calendar